fda drug shortages tirzepatide zepbound shortage status 2025 🚨 Moves to Permanently Shut Down Compounded GLP-1s The FDA is taking steps to eliminate large-scale compounding of GLP-1 medications like semaglutide and tirzepatide, signaling a major shift in how these Drugmakers battle pharmacies over compounded

The consistency of Retatrutide results in clinical trials was remarkable

The company states that each batch undergoes three separate rounds of testing at independent third-party laboratories: Testing Round 1 Identity Verification: According to the company, this confirms the product contains actual BPC-157 rather than filler or substitute compounds, using analytical techniques like mass spectrometry to verify the molecular structure matches authentic BPC-157

Lu F, Vonshak A, Boussiba S

That third target is the same one tirzepatide uses, and its generally believed to improve tolerability of the GLP-1 effect while contributing its own metabolic benefit

Rather than the Mississippi and West Virginia Boards of Pharmacy (BOP) ban the use of semaglutide salt, they banned all forms of semaglutide, even the base version that is the active ingredient in the FDA-approved Ozempic and Wegovy

If you are sick, then you should absolutely check with your doctor before taking any new supplement (including semaglutide, as well as probiotics and synbiotics)